Extension Study of Drisapersen in DMD Subjects
NCT02636686
·
clinicaltrials.gov ↗
NO_LONGER_AVAILABLE
Status
INDUSTRY
Sponsor class
Conditions
Duchenne Muscular Dystrophy
Interventions
DRUG:
Drisapersen
Sponsor
BioMarin Pharmaceutical